Search

Search Results
Results 4521 - 4530 of 4549 for multiple sclerosis
  • Diabex XR 500 and 1000
    Drug - 17 Oct 2022
    Consumer Medicine Information (CMI) about Diabex XR 500 and 1000 intended for persons living in Australia.
  • Diabex
    Drug - 14 Oct 2022
    Consumer Medicine Information (CMI) about Diabex intended for persons living in Australia.
  • Amgevita
    Drug - 7 Sep 2022
    Consumer Medicine Information (CMI) about Amgevita intended for persons living in Australia.
  • Actemra
    Drug - 5 Sep 2022
    Consumer Medicine Information (CMI) about Actemra intended for persons living in Australia.
  • Natrilix SR
    Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Natrilix SR (Sustained Release tablets containing indapamide) intended for persons living in Australia.
  • Natrilix
    Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Natrilix (indapamide) intended for persons living in Australia.
  • Odaplix SR
    Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Odaplix SR (Sustained Release tablets containing indapamide) intended for persons living in Australia.
  • Prexum Combi
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Prexum Combi (perindopril and indapamide) intended for persons living in Australia.
  • Coversyl Plus
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Coversyl Plus (perindopril and indapamide) intended for persons living in Australia.
  • Prexum
    Drug - 15 Jul 2022
    Consumer Medicine Information (CMI) about Prexum (perindopril) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback